Drug‐coated balloons in high‐risk patients and diabetes mellitus: A meta‐analysis of 10 studies
Catheterization and Cardiovascular Interventions · 2024-12 · 104 (7) · 1423-1433
DOI: 10.1002/ccd.31257 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 28.10.2024. Verfasst von Monica Verdoia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, ASL, Biella, Italy. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Cardiac Catheters, Coated Materials, Biocompatible, Coronary Artery Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Despite the improvements in drug eluting stents (DES) technology, suboptimal results have been observed in certain higher‐risk subsets of patients, as in diabetes mellitus (DM). Drug‐coated balloons (DCB) could represent an alternative to DES in complex populations and anatomies, as in DM.
Aims
The present meta‐analysis aimed at assessing the role of DCBs in patients with diabetes mellitus.
Methods
Studies comparing DCB versus percutaneous coronary revascularization (PCI) with/without DES for PCI in high‐risk populations (>30% DM) were included. The primary efficacy endpoint was overall mortality, secondary endpoints were myocardial infarction, target lesion revascularization (TLR), and major adverse cardiovascular events (MACE).
Results
We included 10 studies, comprising 2026 patients. Among them, 1002 patients (49.5%) were treated with DCB and 1024 with DES implantation. Among the included studies, 6 only enrolled diabetic patients and 2 had a prevalence of diabetes of 50%. At a mean follow‐up of 15.3 months, mortality rate was 3.8% (82 patients), significantly lower with DCB (3.2% vs. 4.9% with DES; odds ratio [OR] [95% confidence interval {CI}] = 0.61 [0.38, 0.97], p = 0.04 p het = 0.34. A similar reduction in favor of DCB was observed for MACE (13.6% vs. 17.6%; OR [95% CI] = 0.79 [0.61, 1.04], p = 0.09, p het = 0.25), while TLR was significantly reduced only in the diabetic‐restricted sub‐analysis.
Conclusion
In the present meta‐analysis, we showed a significant survival benefit and an absolute reduction in MACE and TLR with a DCB‐based strategy as compared to DES in high‐risk patients, mostly with DM. Future large‐scale randomized trials, dedicated to this population, are deserved to confirm our findings. What is Known Complex coronary anatomies and diabetes mellitus (DM) represent the pitfall of drug eluting stents (DES), mainly due to inflammatory and thrombotic complications, which should be reduced with drug‐coated balloons (DCB). What is New We confirmed a significant advantage of DCB versus DES in the treatment of de novo lesions in high‐risk patients and mainly in DM, reducing overall mortality, MACE and target lesion revascularization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, ASL, Biella, Italy.
- Department of Internal Medicine, Spedali Civili, Brescia, Italy.
- Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy.
- DCB Academy, Milano, Italy.
ORCID-Profile: Bernardo Cortese
Zitieren
APA
Verdoia, M., Nardin, M., Rognoni, A., & Cortese, B. (2024). Drug‐coated balloons in high‐risk patients and diabetes mellitus: A meta‐analysis of 10 studies. Catheterization and Cardiovascular Interventions, 104(7), 1423-1433. https://doi.org/10.1002/ccd.31257
Vancouver
Verdoia M, Nardin M, Rognoni A, Cortese B. Drug‐coated balloons in high‐risk patients and diabetes mellitus: A meta‐analysis of 10 studies. Catheterization and Cardiovascular Interventions. 2024;104(7):1423-1433. doi:10.1002/ccd.31257
BibTeX
@article{Verdoia2024,
author = {Verdoia, Monica and Nardin, Matteo and Rognoni, Andrea and Cortese, Bernardo},
title = {Drug‐coated balloons in high‐risk patients and diabetes mellitus: A meta‐analysis of 10 studies},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
volume = {104},
number = {7},
pages = {1423--1433},
doi = {10.1002/ccd.31257}
}
EUVIMED